Dexamethasone and FK506 inhibit expression of distinct subsets of chemokines in human mast cells

Journal of Immunology

Volumn 182, Issue 11, 2009, Pages 7233-7243

  Kato, Atsushi ^a,b   Chustz, Regina T ^a   Ogasawara, Takahisa ^b   Kulka, Marianna ^a   Saito, Hirohisa ^b   Schleimerand, Robert P ^a   Matsumoto, Kenji ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CCL1 CHEMOKINE; CCL18 CHEMOKINE; CHEMOKINE; CHYMASE; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CXCL3 CHEMOKINE; DEXAMETHASONE; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 3; PROTEINASE INHIBITOR; TACROLIMUS; UNCLASSIFIED DRUG; ALPHA CHEMOKINE; ANTIBODY; ANTIINFLAMMATORY AGENT; BETA CHEMOKINE; CALCINEURIN; CORTICOSTEROID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CELL STIMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMETRY; DRUG EFFECT; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE TECHNOLOGY; HUMAN; HUMAN CELL; MAST CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; UPREGULATION; CELL CULTURE; DRUG ANTAGONISM; DRUG COMBINATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; ANTIBODIES; CALCINEURIN; CELLS, CULTURED; CHEMOKINES; CHEMOKINES, CC; CHEMOKINES, CXC; DEXAMETHASONE; DRUG THERAPY, COMBINATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENTS; MAST CELLS; RECEPTORS, IGE; TACROLIMUS;

EID: 67449168083     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0801375     Document Type: Article

References (65)

1. Galli, S. J., J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. Williams, and M. Tsai. 2005. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23: 749-786.
2. Kawakami, T., and S. J. Galli. 2002. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2: 773-786.
3. Ono, S. J., T. Nakamura, D. Miyazaki, M. Ohbayashi, M. Dawson, and M. Toda. 2003. Chemokines: roles in leukocyte development, trafficking, and effector function. J. Allergy Clin. Immunol. 111: 1185-1199.
4. Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127. (Pubitemid 30398626)
5. Wakahara, S., Y. Fujii, T. Nakao, K. Tsuritani, T. Hara, H. Saito, and C. Ra. 2001. Gene expression profiles for FcεRI, cytokines and chemokines upon FcεRI activation in human cultured mast cells derived from peripheral blood. Cytokine 16: 143-152.
6. Nakajima, T., N. Inagaki, H. Tanaka, A. Tanaka, M. Yoshikawa, M. Tamari, K. Hasegawa, K. Matsumoto, H. Tachimoto, M. Ebisawa, et al. 2002. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcε receptor I cross-linking: an interspecies comparison. Blood 100: 3861-3868.
7. Homey, B., M. Steinhoff, T. Ruzicka, and D. Y. Leung. 2006. Cytokines and chemokines orchestrate atopic skin inflammation. J. Allergy Clin. Immunol. 118: 178-189.
8. 1998. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 351: 1225-1232.
9. Pearce, N., N. Ait-Khaled, R. Beasley, J. Mallol, U. Keil, E. Mitchell, and C. Robertson. 2007. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 62: 758-766.
10. Weinmayr, G., S. K. Weiland, B. Bjorksten, B. Brunekreef, G. Buchele, W. O. Cookson, L. Garcia-Marcos, M. Gotua, C. Gratziou, M. van Hage, et al. 2007. Atopic sensitization and the international variation of asthma symptom prevalence in children. Am. J. Respir. Crit. Care Med. 176: 565-574.
11. Leung, D. Y., R. Harbeck, P. Bina, R. F. Reiser, E. Yang, D. A. Norris, J. M. Hanifin, and H. A. Sampson. 1993. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: evidence for a new group of allergens. J. Clin. Invest. 92: 1374-1380.
12. Brightling, C. E., P. Bradding, F. A. Symon, S. T. Holgate, A. J. Wardlaw, and I. D. Pavord. 2002. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346: 1699-1705.
13. Carroll, N. G., S. Mutavdzic, and A. L. James. 2002. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur. Respir. J. 19: 879-885.
14. Smit, J. J., and N. W. Lukacs. 2006. A closer look at chemokines and their role in asthmatic responses. Eur. J. Pharmacol. 533: 277-288.
15. Medina-Tato, D. A., M. L. Watson, and S. G. Ward. 2006. Leukocyte navigation mechanisms as targets in airway diseases. Drug Discov. Today 11: 866-879.
16. Kaburagi, Y., Y. Shimada, T. Nagaoka, M. Hasegawa, K. Takehara, and S. Sato. 2001. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1α, MIP-1β, and eotaxin) in patients with atopic dermatitis. Arch. Dermatol. Res. 293: 350-355.
17. Taha, R. A., E. M. Minshall, D. Y. Leung, M. Boguniewicz, A. Luster, S. Muro, M. Toda, and Q. A. Hamid. 2000. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. J. Allergy Clin. Immunol. 105: 1002-1007.
18. Fujisawa, T., R. Fujisawa, Y. Kato, T. Nakayama, A. Morita, H. Katsumata, H. Nishimori, K. Iguchi, H. Kamiya, P. W. Gray, et al. 2002. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J. Allergy Clin. Immunol. 110: 139-146.
19. Nomura, I., B. Gao, M. Boguniewicz, M. A. Darst, J. B. Travers, and D. Y. Leung. 2003. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J. Allergy Clin. Immunol. 112: 1195-1202.
20. Gombert, M., M. C. Dieu-Nosjean, F. Winterberg, E. Bunemann, R. C. Kubitza, L. Da Cunha, A. Haahtela, S. Lehtimaki, A. Muller, J. Rieker, et al. 2005. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J. Immunol. 174: 5082-5091.
21. Pivarcsi, A., M. Gombert, M. C. Dieu-Nosjean, A. Lauerma, R. Kubitza, S. Meller, J. Rieker, A. Muller, L. Da Cunha, A. Haahtela, et al. 2004. CC chemokine ligand 18, an atopic dermatitis-associated and dendritic cell-derived chemokine, is regulated by staphylococcal products and allergen exposure. J. Immunol. 173: 5810-5817.
22. Zou, J., S. Young, F. Zhu, F. Gheyas, S. Skeans, Y. Wan, L. Wang, W. Ding, M. Billah, T. McClanahan, et al. 2002. Microarray profile of differentially expressed genes in a monkey model of allergic asthma. Genome Biol. 3: research0020.
23. Gunther, C., C. Bello-Fernandez, T. Kopp, J. Kund, N. Carballido-Perrig, S. Hinteregger, S. Fassl, C. Schwarzler, G. Lametschwandtner, G. Stingl, et al. 2005. CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells. J. Immunol. 174: 1723-1728.
24. Fahy, J. V., H. E. Fleming, H. H. Wong, J. T. Liu, J. Q. Su, J. Reimann, R. B. Fick, Jr., and H. A. Boushey. 1997. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am. J. Respir. Crit. Care Med. 155: 1828-1834.
25. Busse, W. W. 2007. National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, Summary Report 2007. J. Allergy Clin. Immunol. 120: S94-S138.
26. Ellis, C., T. Luger, D. Abeck, R. Allen, R. A. Graham-Brown, Y. De Prost, L. F. Eichenfield, C. Ferrandiz, A. Giannetti, J. Hanifin, et al. 2003. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br. J. Dermatol. 148(Suppl. 63): 3-10.
27. Rhen, T., and J. A. Cidlowski. 2005. Antiinflammatory action of glucocorticoids: new mechanisms for old drugs. N. Engl. J. Med. 353: 1711-1723.
28. Horne, R. 2006. Compliance, adherence, and concordance: implications for asthma treatment. Chest 130: 65S-72S.
29. Boguniewicz, M., L. F. Eichenfield, and T. Hultsch.2003. Current management of atopic dermatitis and interruption of the atopic march. J. Allergy Clin. Immunol. 112: S140-S150.
30. Ito, K., K. F. Chung, and I. M. Adcock. 2006. Update on glucocorticoid action and resistance. J. Allergy Clin. Immunol. 117: 522-543.
31. Clayton, M. H., D. Y. Leung, W. Surs, and S. J. Szefler. 1995. Altered glucocorticoid receptor binding in atopic dermatitis. J. Allergy Clin. Immunol. 96: 421-423.
32. Hauk, P. J., Q. A. Hamid, G. P. Chrousos, and D. Y. Leung. 2000. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J. Allergy Clin. Immunol. 105: 782-787.
33. Okumura, S., H. Sagara, T. Fukuda, H. Saito, and Y. Okayama. 2005. FcεRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells. J. Allergy Clin. Immunol. 115: 272-279.
34. Matsuda, A., S. Fukuda, K. Matsumoto, and H. Saito. 2007. Th1/Th2 Cytokines reciprocally regulate in vitro pulmonary angiogenesis via CXC chemokine synthesis. Am. J. Respir. Cell Mol. Biol. 38: 168-175.
35. Ashcroft, D. M., P. Dimmock, R. Garside, K. Stein, and H. C. Williams. 2005. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. Br. Med. J. 330: 516.
36. Pratt, W. B., and D. O. Toft. 1997. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 18: 306-360.
37. Niven, A. S., and G. Argyros. 2003. Alternate treatments in asthma. Chest 123: 1254-1265.
38. Schleimer, R. P., E. S. Schulman, D. W. MacGlashan, Jr., S. P. Peters, E. C. Hayes, G. K. Adams, 3rd, L. M. Lichtenstein, and N. F. Adkinson, Jr. 1983. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J. Clin. Invest. 71: 1830-1835.
39. Smith, S. J., A. M. Piliponsky, F. Rosenhead, U. Elchalal, A. Nagler, and F. Levi-Schaffer. 2002. Dexamethasone inhibits maturation, cytokine production and FcεRI expression of human cord blood-derived mast cells. Clin. Exp. Allergy 32: 906-913.
40. de Paulis, A., C. Stellato, R. Cirillo, A. Ciccarelli, A. Oriente, and G. Marone. 1992. Anti-inflammatory effect of FK-506 on human skin mast cells. J. Invest. Dermatol. 99: 723-728.
41. Zuberbier, T., S. U. Chong, K. Grunow, S. Guhl, P. Welker, M. Grassberger, and B. M. Henz. 2001. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils. J. Allergy Clin. Immunol. 108: 275-280.
42. Holm, M., H. Kvistgaard, C. Dahl, H. B. Andersen, T. K. Hansen, P. O. Schiotz, and S. Junker. 2006. Modulation of chemokine gene expression in CD133 cord blood-derived human mast cells by cyclosporin A and dexamethasone. Scand. J. Immunol. 64: 571-579.
43. Iida, M., K. Matsumoto, H. Tomita, T. Nakajima, A. Akasawa, N. Y. Ohtani, N. L. Yoshida, K. Matsui, A. Nakada, Y. Sugita, et al. 2001. Selective downregulation of high-affinity IgE receptor (FcεRI) α-chain messenger RNA among transcriptome in cord blood-derived versus adult peripheral blood-derived cultured human mast cells. Blood 97: 1016-1022.
44. Saito, H., A. Kato, K. Matsumoto, and Y. Okayama. 2006. Culture of human mast cells from peripheral blood progenitors. Nat. Protocol. 1: 2178-2183.
45. Nomura, I., T. Katsunuma, K. Matsumoto, M. Iida, H. Tomita, M. Tomikawa, H. Kawahara, A. Akasawa, R. Pawankar, and H. Saito. 2001. Human mast cell progenitors in peripheral blood from atopic subjects with high IgE levels. Clin. Exp. Allergy 31: 1424-1431.
46. Kato, A., T. Homma, J. Batchelor, N. Hashimoto, S. Imai, H. Wakiguchi, H. Saito, and K. Matsumoto. 2003. Interferon-α/β receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006. BMC Immunol. 4: 8.
47. Kato, A., T. Ogasawara, T. Homma, H. Saito, and K. Matsumoto. 2004. Lipopolysaccharide-binding protein critically regulates lipopolysaccharide- induced IFN-β signaling pathway in human monocytes. J. Immunol. 172: 6185-6194. (Pubitemid 38621224)
48. Williams, H. C. 2005. Clinical practice: atopic dermatitis. N. Engl. J. Med. 352: 2314-2324.
49. Leung, D. Y., M. Boguniewicz, M. D. Howell, I. Nomura, and Q. A. Hamid. 2004. New insights into atopic dermatitis. J. Clin. Invest. 113: 651-657.
50. Pang, L., M. Nie, L. Corbett, A. Sutcliffe, and A. J. Knox. 2006. Mast cell β-tryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities. J. Immunol. 176: 3788-3795. (Pubitemid 43364027)
51. Zhao, W., C. A. Oskeritzian, A. L. Pozez, and L. B. Schwartz. 2005. Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines. J. Immunol. 175: 2635-2642. (Pubitemid 41113878)
52. Sengoku, T., S. Kishi, S. Sakuma, Y. Ohkubo, and T. Goto. 2000. FK506 inhibition of histamine release and cytokine production by mast cells and basophils. Int. J. Immunopharmacol. 22: 189-201.
53. Caproni, M., D. Torchia, E. Antiga, M. Terranova, W. Volpi, E. del Bianco, A. D'Agata, and P. Fabbri. 2007. The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study. Br. J. Dermatol. 156: 312-319.
54. Siraganian, R. P. 2003. Mast cell signal transduction from the high-affinity IgE receptor. Curr. Opin. Immunol. 15: 639-646.
55. Rivera, J., J. R. Cordero, Y. Furumoto, C. Luciano-Montalvo, C. Gonzalez-Espinosa, M. Kovarova, S. Odom, and V. Parravicini. 2002. Macromolecular protein signaling complexes and mast cell responses: a view of the organization of IgE-dependent mast cell signaling. Mol. Immunol. 38: 1253-1258.
56. Stellato, C., S. Matsukura, A. Fal, J. White, L. A. Beck, D. Proud, and R. P. Schleimer. 1999. Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J. Immunol. 163: 5624-5632.
57. Poon, M., B. Liu, and M. B. Taubman. 1999. Identification of a novel dexamethasone-sensitive RNA-destabilizing region on rat monocyte chemoattractant protein 1 mRNA. Mol. Cell Biol. 19: 6471-6478.
58. Tobler, A., R. Meier, M. Seitz, B. Dewald, M. Baggiolini, and M. F. Fey. 1992. Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 79: 45-51.
59. Scheinman, R. I., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin, Jr. 1995. Role of transcriptional activation of IκB alpha in mediation of immunosuppression by glucocorticoids. Science 270: 283-286.
60. Rao, A., C. Luo, and P. G. Hogan. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15: 707-747.
61. Martinez-Martinez, S., and J. M. Redondo. 2004. Inhibitors of the calcineurin/NFAT pathway. Curr. Med. Chem. 11: 997-1007.
62. Kel, A., N. Voss, R. Jauregui, O. Kel-Margoulis, and E. Wingender. 2006. Beyond microarrays: finding key transcription factors controlling signal transduction pathways. BMC Bioinformatics. 7(Suppl. 2): S13.
63. Nakahara, T., T. Koga, S. Fukagawa, H. Uchi, and M. Furue. 2004. Intermittent topical corticosteroid/tacrolimus sequential therapy improves lichenification and chronic papules more efficiently than intermittent topical corticosteroid/emollient sequential therapy in patients with atopic dermatitis. J. Dermatol. 31: 524-528. (Pubitemid 39045007)
64. Yuyama, N., D. E. Davies, M. Akaiwa, K. Matsui, Y. Hamasaki, Y. Suminami, N. L. Yoshida, M. Maeda, A. Pandit, J. L. Lordan, et al. 2002. Analysis of novel disease-related genes in bronchial asthma. Cytokine 19: 287-296.
65. Sakata, Y., K. Arima, T. Takai, W. Sakurai, K. Masumoto, N. Yuyama, Y. Suminami, F. Kishi, T. Yamashita, T. Kato, et al. 2004. The squamous cell carcinoma antigen 2 inhibits the cysteine proteinase activity of a major mite allergen, Der p 1. J. Biol. Chem. 279: 5081-5087.